Filgrastim Active Not Recruiting Phase 1 Trials for Multiple Myeloma, Refractory to Standard Treatment / Relapsed Multiple Myeloma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02043847Total Marrow Irradiation With High Dose Melphalan Prior to Autologous Transplant for Relapsed or Refractory Multiple Myeloma (BMT-03)